StockIQpro
NASDAQ:FEMY

Femasys Inc.

Femasys Inc.'s revenue grew 40.8% in fiscal 2025 to $2.3M while operating margin rose to −767.0%. Free cash flow was −$19.2M, −837.9% of revenue, and the diluted share count rose 77.6%.Summary generated from Femasys Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.

Revenue (FY25)$2.3M
Revenue growth+40.8%
Revenue, 5-yr CAGR+17.2%
Gross margin62.0%
Operating margin−767.0%
Net margin−812.3%
ROICn/a
Return on equity−455.8%
Debt / equityn/a
Free cash flow−$19.2M
FCF margin−837.9%
Share count change+77.6%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue11122
Operating income−8−12−15−18−18
Net income−8−11−14−19−19
Free cash flow−8−11−11−20−19

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus